You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Cumulus Neuroscience begins studies of digital biomarker

Cumulus Neuroscience has announced the beginning of new clinical studies to investigate the company’s digital biomarker in quantifying cognitive decline over time, in patients with conditions such as dementia and Alzheimer’s disease.